EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,980,000 | -36.9% | 149,911 | -2.4% | 0.00% | -40.0% |
Q3 2021 | $6,312,000 | -25.8% | 153,647 | +2.3% | 0.01% | -16.7% |
Q2 2021 | $8,510,000 | -13.5% | 150,245 | -35.8% | 0.01% | -14.3% |
Q1 2021 | $9,835,000 | -8.5% | 234,161 | +52.7% | 0.01% | -12.5% |
Q4 2020 | $10,751,000 | +167.8% | 153,351 | +7.2% | 0.01% | +100.0% |
Q3 2020 | $4,014,000 | +9.8% | 143,061 | +15.7% | 0.00% | 0.0% |
Q2 2020 | $3,656,000 | +60.1% | 123,602 | +7.3% | 0.00% | +33.3% |
Q1 2020 | $2,284,000 | -33.6% | 115,195 | -0.9% | 0.00% | 0.0% |
Q4 2019 | $3,441,000 | +62.2% | 116,195 | +24.5% | 0.00% | +50.0% |
Q3 2019 | $2,122,000 | +42.5% | 93,300 | +55.0% | 0.00% | 0.0% |
Q2 2019 | $1,489,000 | -0.7% | 60,200 | -1.8% | 0.00% | 0.0% |
Q1 2019 | $1,499,000 | -7.3% | 61,300 | -13.8% | 0.00% | 0.0% |
Q4 2018 | $1,617,000 | +14.8% | 71,082 | +60.5% | 0.00% | 0.0% |
Q3 2018 | $1,409,000 | -22.4% | 44,282 | -12.6% | 0.00% | -33.3% |
Q2 2018 | $1,815,000 | – | 50,642 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |